Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment.
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001706:Biopsy; D002738:Chloroquine; D002908:Chronic Disease; D003048:Coccidiosis / Q000473:pathology* / Q000628:therapy; D003937:Diagnosis, Differential; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D004035:Diet Therapy; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D007421:Intestine, Small / Q000473:pathology*; D007549:Isospora / Q000302:isolation & purification; D007583:Jejunum / Q000473:pathology; D008286:Malabsorption Syndromes / Q000209:etiology / Q000473:pathology; D008297:Male; D008795:Metronidazole; D008854:Microscopy, Electron; D008875:Middle Aged; D009582:Nitrofurantoin; D011319:Primaquine; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine; D013411:Sulfadiazine / Q000627:therapeutic use; D013752:Tetracycline; D013997:Time Factors
D000981:Antiprotozoal Agents; D013411:Sulfadiazine; D008795:Metronidazole; D002738:Chloroquine; D009582:Nitrofurantoin; D013752:Tetracycline; D011796:Quinacrine; D011319:Primaquine; D011739:Pyrimethamine